The technology that allows scientists to profile the entire genome of individual tumors offers new hope for discovering ways to select the best treatment for each patient's particular type of cancer. However, these profiles produce huge amounts of data, and the volume alone creates unique analytical problems.
In a study published on-line this week in the journal BMC Medical Genomics, researchers from Huntsman Cancer Institute (HCI) at the University of Utah describe a new analytical approach based on a concept called multiplicity, that can organize large amounts of varied genetic data. The method allows researchers to create three-dimensional models revealing previously unknown relationships among the genes involved with different types of cancer.
"This technique shows similar genetic profiles for different types of cancers, which could open the door to trials of already approved drugs for additional cancers," said Lewis Frey, PhD, assistant professor in the Department of Biomedical Informatics and an HCI investigator. "It can bring to light previously unknown genetic connections between different cancers, helping focus the search for cancer-causing genetic mutations. It makes whole genome data more usable for both clinical and laboratory researchers."
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery